Aspirin And Extended-release Dipyridamole Capsule, Extended Release
Product Images NDC 42571-274

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Aspirin And Extended-release Dipyridamole (NDC 42571-274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cumulative Stroke Rate Figure (Aspirindipyridamole Figure1)

A line graph showing cumulative stroke rate (%) over 24 months of follow-up for different treatment groups: ASA & extended-release dipyridamole capsule, ASA alone, extended-release dipyridamole (ER-DP), and placebo. The chart compares stroke rates for these groups across the study duration.*

FDA Label Image

Aspirindipyridamole Lbl

Label for Aspirin and Extended-Release Dipyridamole Capsules 25 mg/200 mg, unit-of-use container with 60 capsules, manufactured by Micro Labs Limited. The label includes storage instructions, pharmacist guidance, NDC 42571-274-60, and manufacturer addresses in India and USA. Features a barcode and Micro Labs logo.*

FDA Label Image

Aspirin Structure (Aspirindipyridamole Strc2)

Chemical structure of aspirin (acetylsalicylic acid) showing its molecular formula C9H8O4 and molecular weight 180.16.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.